ARN de tête épissé : Questions médicales fréquentes
Nom anglais: RNA, Spliced Leader
Descriptor UI:D020038
Tree Number:D13.444.735.790.552.968
Termes MeSH sélectionnés :
Pilot Projects
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "ARN de tête épissé : Questions médicales les plus fréquentes",
"headline": "ARN de tête épissé : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les ARN de tête épissé : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-26",
"dateModified": "2025-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "ARN de tête épissé"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Petit ARN non traduit",
"url": "https://questionsmedicales.fr/mesh/D058727",
"about": {
"@type": "MedicalCondition",
"name": "Petit ARN non traduit",
"code": {
"@type": "MedicalCode",
"code": "D058727",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.444.735.790.552"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "ARN de tête épissé",
"alternateName": "RNA, Spliced Leader",
"code": {
"@type": "MedicalCode",
"code": "D020038",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Omar Abdel-Wahab",
"url": "https://questionsmedicales.fr/author/Omar%20Abdel-Wahab",
"affiliation": {
"@type": "Organization",
"name": "Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA."
}
},
{
"@type": "Person",
"name": "Akihide Yoshimi",
"url": "https://questionsmedicales.fr/author/Akihide%20Yoshimi",
"affiliation": {
"@type": "Organization",
"name": "Division of Cancer RNA Research, National Cancer Center Research Institute."
}
},
{
"@type": "Person",
"name": "Berndt Müller",
"url": "https://questionsmedicales.fr/author/Berndt%20M%C3%BCller",
"affiliation": {
"@type": "Organization",
"name": "School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, UK."
}
},
{
"@type": "Person",
"name": "Jonathan Pettitt",
"url": "https://questionsmedicales.fr/author/Jonathan%20Pettitt",
"affiliation": {
"@type": "Organization",
"name": "School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, UK."
}
},
{
"@type": "Person",
"name": "Rik Hendrickx",
"url": "https://questionsmedicales.fr/author/Rik%20Hendrickx",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Antwerp, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.",
"datePublished": "2022-08-01",
"url": "https://questionsmedicales.fr/article/35916049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2022.37.e241"
}
},
{
"@type": "ScholarlyArticle",
"name": "[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].",
"datePublished": "2022-10-07",
"url": "https://questionsmedicales.fr/article/36205744",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-022-01945-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36427493",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1902-6326"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37316688",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10995-023-03732-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/37543936",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/aim.2023.22"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides nucléiques",
"item": "https://questionsmedicales.fr/mesh/D009696"
},
{
"@type": "ListItem",
"position": 4,
"name": "ARN",
"item": "https://questionsmedicales.fr/mesh/D012313"
},
{
"@type": "ListItem",
"position": 5,
"name": "ARN non traduit",
"item": "https://questionsmedicales.fr/mesh/D022661"
},
{
"@type": "ListItem",
"position": 6,
"name": "Petit ARN non traduit",
"item": "https://questionsmedicales.fr/mesh/D058727"
},
{
"@type": "ListItem",
"position": 7,
"name": "ARN de tête épissé",
"item": "https://questionsmedicales.fr/mesh/D020038"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : ARN de tête épissé - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur ARN de tête épissé",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur ARN de tête épissé",
"description": "Comment détecte-t-on l'ARN de tête épissé ?\nQuels tests sont utilisés pour l'analyse de l'ARN ?\nL'ARN de tête épissé est-il spécifique à certaines espèces ?\nPeut-on quantifier l'ARN de tête épissé ?\nQuels marqueurs sont utilisés pour l'ARN épissé ?",
"url": "https://questionsmedicales.fr/mesh/D020038?mesh_terms=Pilot+Projects&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur ARN de tête épissé",
"description": "Quels symptômes sont associés aux infections parasitaires ?\nL'ARN de tête épissé cause-t-il des symptômes directs ?\nComment l'ARN de tête épissé affecte-t-il la santé ?\nY a-t-il des symptômes spécifiques aux trypanosomoses ?\nLes symptômes varient-ils selon le type de parasite ?",
"url": "https://questionsmedicales.fr/mesh/D020038?mesh_terms=Pilot+Projects&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur ARN de tête épissé",
"description": "Quelles mesures préventives contre les parasites ?\nLes vaccins existent-ils pour prévenir les infections parasitaires ?\nComment réduire le risque d'infection parasitaire ?\nL'éducation joue-t-elle un rôle dans la prévention ?\nLes voyages augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D020038?mesh_terms=Pilot+Projects&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur ARN de tête épissé",
"description": "Quels traitements sont efficaces contre les infections parasitaires ?\nL'ARN de tête épissé influence-t-il le choix du traitement ?\nY a-t-il des traitements préventifs pour les infections ?\nLes traitements sont-ils les mêmes pour tous les parasites ?\nComment surveiller l'efficacité du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D020038?mesh_terms=Pilot+Projects&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur ARN de tête épissé",
"description": "Quelles complications peuvent survenir avec les infections parasitaires ?\nL'ARN de tête épissé est-il lié à des complications ?\nLes complications sont-elles réversibles ?\nComment prévenir les complications des infections ?\nLes complications varient-elles selon le parasite ?",
"url": "https://questionsmedicales.fr/mesh/D020038?mesh_terms=Pilot+Projects&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur ARN de tête épissé",
"description": "Quels sont les principaux facteurs de risque d'infection parasitaire ?\nL'immunité affecte-t-elle le risque d'infection ?\nLes conditions environnementales influencent-elles le risque ?\nLes comportements à risque augmentent-ils le risque d'infection ?\nLes populations vulnérables sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D020038?mesh_terms=Pilot+Projects&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on l'ARN de tête épissé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des techniques comme la PCR et le séquençage pour l'identifier."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'analyse de l'ARN ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrophorèse et le Northern blot pour visualiser l'ARN."
}
},
{
"@type": "Question",
"name": "L'ARN de tête épissé est-il spécifique à certaines espèces ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est souvent spécifique à certains parasites comme les trypanosomes."
}
},
{
"@type": "Question",
"name": "Peut-on quantifier l'ARN de tête épissé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des méthodes comme la RT-qPCR permettent de quantifier cet ARN."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour l'ARN épissé ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs spécifiques de l'épissage sont utilisés pour l'identification."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux infections parasitaires ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, fatigue, et douleurs abdominales selon le parasite."
}
},
{
"@type": "Question",
"name": "L'ARN de tête épissé cause-t-il des symptômes directs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est un indicateur de l'infection plutôt qu'une cause de symptômes."
}
},
{
"@type": "Question",
"name": "Comment l'ARN de tête épissé affecte-t-il la santé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut indiquer une infection active, mais ne cause pas de symptômes directement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux trypanosomoses ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les trypanosomoses peuvent provoquer des symptômes neurologiques et cardiaques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de parasite ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque parasite peut provoquer un ensemble de symptômes distincts."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives contre les parasites ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures incluent l'hygiène, la cuisson des aliments et l'utilisation de répulsifs."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour prévenir les infections parasitaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, peu de vaccins sont disponibles pour les infections parasitaires."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'infection parasitaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les zones à risque et pratiquer une bonne hygiène personnelle aide à réduire le risque."
}
},
{
"@type": "Question",
"name": "L'éducation joue-t-elle un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les risques et les mesures préventives est cruciale."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endommagées augmente le risque d'infections parasitaires."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre les infections parasitaires ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des antiparasitaires comme la pentamidine et le nifurtimox."
}
},
{
"@type": "Question",
"name": "L'ARN de tête épissé influence-t-il le choix du traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sa présence peut guider le choix du traitement en fonction du parasite."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs pour les infections ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements préventifs existent, comme la prophylaxie pour certaines maladies."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les parasites ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque type de parasite nécessite un traitement spécifique."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "On surveille l'efficacité par des tests de suivi et l'évaluation des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les infections parasitaires ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques, cardiaques et des infections secondaires."
}
},
{
"@type": "Question",
"name": "L'ARN de tête épissé est-il lié à des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut indiquer une infection active, ce qui peut entraîner des complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications des infections ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic précoce et un traitement rapide aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le parasite ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque parasite peut entraîner des complications différentes selon l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection parasitaire ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le voyage dans des zones endommagées et l'exposition à des vecteurs."
}
},
{
"@type": "Question",
"name": "L'immunité affecte-t-elle le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une immunité affaiblie augmente le risque d'infections parasitaires."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales influencent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme l'humidité et la chaleur favorisent la prolifération des parasites."
}
},
{
"@type": "Question",
"name": "Les comportements à risque augmentent-ils le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements comme la consommation d'eau non traitée augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les populations vulnérables sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées sont souvent plus vulnérables aux infections."
}
}
]
}
]
}
This study investigated the demand for and awareness of a primary healthcare pilot project for people with disabilities; it also sought to identify relevant determinants for demand and awareness using...
This study is a secondary analysis of data from the population-based survey conducted in Gyeonggi Regional Health & Medical Center for People with Disabilities. The data was designed with quota ra...
Awareness of the service (12.1%) was remarkably low, while the demand (80.5%) was high. The gap between respondents who needed the service but were unaware of it differed according to age, education, ...
Chronic disease and an unmet need for medical care were key determinants of service demand, while the severity of disability was not. Thus, there is a need to review the initiative that defines servic...
Communication and interprofessional collaboration with patients diagnosed with cancer is challenging. Structured communication training has not yet been integrated into postgraduate medical education....
A needs assessment was conducted using focus groups and individual interviews. Learning objectives were aligned with (inter)national learning objective catalogs. The ICT was developed using the six-st...
Physician participation rates in the workshops were 83.0% and nursing participation rates were 58.3%. Utilization of the workplace-based training was 97%. The physicians evaluated the ICT very positiv...
The implementation of an ICT with 80 teaching units is successfully feasible in a urological clinic and leads to a sustainable improvement of the communication culture, among other things through ment...
Analysis of psychiatric-psychotherapeutic crisis services in the Leipzig Psychiatry Network (LeiP#netz), assigning the services to the functional areas of the FBM according to Steinhart and Wienberg....
A standardized survey of crisis care was conducted using the functions "complex outpatient treatment", "access to acute psychotherapy in crisis", and "24 h complex, intensive treatment" by means of fa...
A total of 31 measures were recorded for the three functions. All crisis care services were highly utilized; in up to one-third of cases, no services could be provided when demand was requested. Servi...
Crisis care services for severely mentally ill people are available in various constellations in the study region. Low-threshold 24/7 crisis services need to be expanded....
Social determinants of health (SDOH) and stress during pregnancy may contribute to adverse pregnancy outcomes. The objective of this in the field pilot project was to develop a comprehensive screening...
Pregnant patients accessing prenatal care at a single site of an urban Federally Qualified Health Center were recruited during prenatal visits to complete a Social Determinants of Health in Pregnancy ...
Between April 2018 and March 2019, 135 pregnant participants completed SIPT. Ninety-one percent of patients scored positive on at least one screener, 54% to three or more screeners....
Despite guidelines to screen for SDOH during pregnancy there is no universal tool. Our pilot project demonstrated the concurrent use of adapted screening tools where participants reported at least one...
Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative feca...
In this feasibility study, 7039 individuals aged 50-75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHW...
Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested posi...
Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healt...
Evidence synthesis organisations are trying to meet commissioners' needs for rapid responses to their evidence synthesis commissions. In this project we piloted an intensive process, working to comple...
In a pre-planning phase, an intensive work group was established, and two commissions were selected for this pilot project. The evidence synthesis process was divided into two phases: planning and int...
During the planning phase, teams identified significant uncertainties regarding scopes, research questions, and inclusion criteria. To address this, they engaged with commissioners earlier than origin...
Overall, the intensive process fostered focus and productivity, allowing teams to manage short-term deliverables effectively. The researchers preferred working intensively with one evidence synthesis ...
Families with one parent suffering from cancer are exposed to extraordinary emotional and organizational burdens, affecting underaged children. To help coordinated access to social and logistic suppor...
A cross-sectional observational study was conducted using a mixed-method approach. Semi-structured written expert surveys (n=10) and secondary analysis of routine data of the care model (n=171 familie...
Quantitative secondary analysis: The participating families had 1-7 children (median (m) 2, range (s) 6). In 66% of the cases, the mother was affected by cancer, in 20% the diseased parent was in a si...
The data collected indicate that in families, matching the German average in their socio-demographic characteristics, a great need for organizational support develops as soon as one parent becomes sic...
We initiate the Westlake BioBank for Chinese (WBBC) pilot project with 4,535 whole-genome sequencing (WGS) individuals and 5,841 high-density genotyping individuals, and identify 81.5 million SNPs and...
To report a pilot project of expert nurses for outpatient parenteral antimicrobial treatment (OPAT) follow-up....
Three nurses with specific training on antibiotics started a state-funded programme including: i) consultations for OPAT follow-up; ii) hotline for satellite hospitals; iii) peer training. Patients' d...
From December 2020 to December 2021, 118 patients (median age 66.5 years [52-75], male-to-female ratio 2.5) were enrolled, for a total of 621 consultations. Patients were mostly on OPAT for bone and j...
Nurses may be important actors for OPAT follow-up....
The Fellowship Council (FC) is transitioning to a competency-based medical education (CBME) model, including the introduction of Entrustable Professional Activities (EPAs) for training and assessment ...
The FC coordinated the development of EPAs in collaboration with the sponsoring societies for Advanced GI/MIS, Bariatrics, Foregut, Endoscopy and Hepatopancreaticobiliary (HPB) fellowships encompassin...
The 15 participating programs included 18 fellows and 106 faculty. A total of 655 assessments were initiated with 429 (65%) completed. The average (SD) number of EPAs completed for each fellow was 24(...
A competency-based assessment framework was developed by the FC and piloted in several programs. Participation was variable and required ongoing strategies to address barriers. The pilot project has p...
